Displaying 1 - 50 of 164 results
Released Company Title Industry Topic
11 Jun 2024
07:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics Announces mRNA-LNP Cancer Vaccine Demonstrates Superior Efficacy 20103010 Biotechnology Non-regulatory press releases
24 May 2024
17:15 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Grant of share options 20103010 Biotechnology Mandatory notification of trade primary insiders
16 May 2024
11:46 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics ASA - Minutes of Annual General Meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
14 May 2024
07:15 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics Announces Clinical Collaboration with MSD to Evaluate VB10.16 in Combination with KEYTRUDA® (pembrolizumab) in Patients with HPV16-Positive High-Risk Locally Advanced Cervical Cancer 20103010 Biotechnology Non-regulatory press releases
14 May 2024
07:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Quarterly report Q1 2024 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
07 May 2024
07:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics – invitation to Q1 2024 financial results presentation 20103010 Biotechnology Non-regulatory press releases
25 Apr 2024
07:30 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics ASA - Notice of Annual General Meeting 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
19 Apr 2024
07:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics Initiates Phase 2 Trial of VB10.16 in Second Line HPV16-Positive Cervical Cancer 20103010 Biotechnology Non-regulatory press releases
19 Apr 2024
06:30 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Annual Report 2023 20103010 Biotechnology Annual financial and audit Reports
26 Mar 2024
15:30 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders
21 Mar 2024
19:38 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders
21 Mar 2024
07:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics Announces Topline Conclusions Affirming Prolonged Clinical Benefits from Matured Survival Data in Phase 2 C-02 Trial in Advanced Cervical Cancer 20103010 Biotechnology Non-regulatory press releases
19 Mar 2024
07:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics Announces Advances in the Inverse Vaccine Platform With the Potential to Treat Autoimmune Diseases 20103010 Biotechnology Non-regulatory press releases
13 Mar 2024
14:57 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders
08 Mar 2024
16:16 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders
08 Mar 2024
13:31 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders
04 Mar 2024
13:11 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders
29 Feb 2024
16:27 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders
28 Feb 2024
07:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Quarterly report Q4 2023 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
22 Feb 2024
07:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics – invitation to Q4 2023 financial results presentation 20103010 Biotechnology Non-regulatory press releases
19 Dec 2023
07:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference 20103010 Biotechnology Non-regulatory press releases
18 Dec 2023
21:19 CET
NYKODE THERAPEUTICS ASA Financial calendar 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
14 Dec 2023
07:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics Announces Expansion of Oncology Pipeline Aiming to Reduce the Burden of Colorectal Cancer 20103010 Biotechnology Non-regulatory press releases
07 Dec 2023
18:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Share capital increase from exercise of warrants 20103010 Biotechnology Total number of voting rights and capital
28 Nov 2023
10:49 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Share capital increase from exercise of warrants 20103010 Biotechnology Total number of voting rights and capital
24 Nov 2023
18:20 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics – Primary insider transaction 20103010 Biotechnology Mandatory notification of trade primary insiders
15 Nov 2023
07:00 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Quarterly report Q3 2023 20103010 Biotechnology Half yearly financial reports and audit reports/limited reviews
10 Nov 2023
17:13 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Share capital increase from exercise of warrants 20103010 Biotechnology Total number of voting rights and capital
09 Nov 2023
08:30 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics – invitation to Q3 2023 financial results presentation 20103010 Biotechnology Non-regulatory press releases
07 Nov 2023
08:30 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics to Present at Jefferies Healthcare Conference 20103010 Biotechnology Non-regulatory press releases
31 Oct 2023
15:30 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders
31 Oct 2023
14:41 CET
NYKODE THERAPEUTICS ASA Disclosure of shareholding 20103010 Biotechnology Major shareholding notifications
31 Oct 2023
09:16 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics ASA – New Share Capital Registered 20103010 Biotechnology Total number of voting rights and capital
30 Oct 2023
23:29 CET
NYKODE THERAPEUTICS ASA Nykode Therapeutics ASA – Subsequent Offering Cancelled 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
27 Oct 2023
16:15 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider 20103010 Biotechnology Mandatory notification of trade primary insiders
25 Oct 2023
17:22 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of trade by closely associated party of a primary Insider 20103010 Biotechnology Mandatory notification of trade primary insiders
25 Oct 2023
15:32 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Mandatory notification of trade by closely associated party of a primary Insider 20103010 Biotechnology Mandatory notification of trade primary insiders
25 Oct 2023
14:33 CEST
NYKODE THERAPEUTICS ASA Disclosure of shareholding 20103010 Biotechnology Major shareholding notifications
25 Oct 2023
08:15 CEST
NYKODE THERAPEUTICS ASA Disclosure of shareholding 20103010 Biotechnology Major shareholding notifications
25 Oct 2023
02:05 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics ASA – Share Lending by Closely Associated Parties of a Primary Insider 20103010 Biotechnology Mandatory notification of trade primary insiders
25 Oct 2023
01:54 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics ASA – Key Information Regarding Subsequent Offering 20103010 Biotechnology Additional regulated information required to be disclosed under the laws of a Member State
25 Oct 2023
01:50 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics ASA - Private Placement Completed 20103010 Biotechnology Inside information
24 Oct 2023
16:30 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics ASA - Contemplated Private Placement 20103010 Biotechnology Inside information
23 Oct 2023
20:58 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Update on process with the Norwegian Tax Authorities 20103010 Biotechnology Non-regulatory press releases
12 Oct 2023
16:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics – presentation from the mRNA Cancer Vaccines Summit 2023 in Boston 20103010 Biotechnology Non-regulatory press releases
09 Oct 2023
06:45 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics to Present at the mRNA Cancer Vaccines Summit 2023 in Boston 20103010 Biotechnology Non-regulatory press releases
29 Sep 2023
07:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics Initiates Phase 1/2a Trial of VB10.16 in First Line HPV16-Positive Head and Neck Cancer 20103010 Biotechnology Non-regulatory press releases
27 Sep 2023
14:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics - presentation from Capital Markets Day in Oslo 20103010 Biotechnology Non-regulatory press releases
25 Sep 2023
08:30 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics - Invitation to Capital Markets Day in Oslo on September 27, 2023 20103010 Biotechnology Non-regulatory press releases
20 Sep 2023
16:00 CEST
NYKODE THERAPEUTICS ASA Nykode Therapeutics Announces Advances in Clinical Pipeline and Research 20103010 Biotechnology Non-regulatory press releases